Add to My Stocks
$0.34 $0 (0%) AGYTF stock closing price Sep 19, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our ALLERGY THERAPT stock analysis. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate ALLERGY THERAPT stock analysis. A company releases its balance sheet every quarter along with its quarterly results. The balance sheet shows total liabilities of $38.48M and shareholders equity of $47.64M. ALLERGY THERAPT revenue and ALLERGY THERAPT operating cash flow are important in understanding the financial capacity of the company.

View and download ALLERGY THERAPT quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Fiscal year is Jul - Jun2018 Q22017 Q22016 Q4
Marketable Securities---
Raw Materials--2.38M
Work In Progress--4.66M
Finished Goods--4.37M
Notes Receivable---
Other Current Assets---
Total Current Assets
Property Plant & Equipment--33.63M
Accumulated Depreciation--19.28M
Net Property Plant & Equipment
Investment & Advances6.44M5.33M6M
Other Non-Current Assets---
Deferred Charges---
Deposits & Other Assets---
Total Assets
Notes Payable---
Accounts Payable19.49M15.38M16.38M
Current Portion Long-Term Debt---
Current Portion Capital Leases---
Accrued Expenses---
Income Taxes Payable---
Other Current Liabilities--1.75M
Total Current Liabilities
Deferred Taxes/Income---
Convertible Debt---
Long-Term Debt3.71M3.81M4.55M
Non-Current Capital Leases---
Other Long-Term Liabilities13.81M12.23M15.47M
Total Liabilities
Minority Interest---
Preferred Stock---
Common Stock Net---
Capital Surplus135.92M127.29M151.93M
Retained Earnings-143.88M-131.79M-169.02M
Treasury Stock---
Other Liabilities54.8M51.55M61.19M
Shareholders Equity47.64M47.8M44.99M
Total Liabilities & Shareholders Equity86.13M80.61M84.1M
All figures in USD. M: Millions of USD, B: Billions of USD.

Looking at ALLERGY THERAPT historical stock prices and the current ALLERGY THERAPT stock price can tell you how the stock price has moved, whereas the ALLERGY THERAPT PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: An asset is a resource that a corporation like ALLERGY THERAPT owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for AGYTF stock as of 2018 Q2 is $86.13M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: The total liabilities of ALLERGY THERAPT for the quarter 2018 Q2 total to $38.48M. Liabilities for a company like ALLERGY THERAPT include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

ALLERGY THERAPT Balance Sheet - Key Ratios